| AMGEN INC. DL-,0001 | 213.150 / +0.57% |
| Date/Time | 12/13 / 18:30 |
| Chg. / Chg.(%) | 1.200 / +0.57% |
| Bid | 212.750 / 2000 |
| Ask | 213.150 / 2000 |
| Open | 212.200 |
| Previous Close | 211.950 |
| High | 213.650 |
| Low | 211.900 |
| Volume [EUR] | 33,347.100 |
| Volume [Units] | 157 |
| Price fixings | 7 |
| ISIN | US0311621009 |
| Security | AMG |
| Exchange | Stuttgart |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 212.600 | ||
| NASDAQ | 236.7400 |  |
2,041,194 |
| Cboe US | 236.74 | |
157,115 |
| IEX | 236.75 | |
63,751 |
| London Inter.. | 238.03 |  |
12,361 |
| TradeGate | 213.550 | |
1,192 |
| Mexico | 4,512.12 |  |
522 |
| Xetra | 213.05 | |
215 |
| Frankfurt | 214.0000 | |
177 |
| Stuttgart | 213.150 | |
157 |
| München | 213.35 | |
51 |
| Berlin | 212.60 | |
35 |
| gettex | 213.650 | |
31 |
| Hannover | 212.00 | |
13 |
| Vienna Globa.. | 213.15 | |
0 |
| Düsseldorf | 211.55 | |
0 |
| Hamburg | 211.90 | |
0 |
| SIX Swiss Ex.. | 184.90 | |
|
| SIX Swiss Ex.. | 179.83 | |
|
| Borsa Italia.. | 213.10 | 50 | |
| Borsa Italia.. | 213.10 |
News
- CEO Roundtable on Cancer Appoints Andrew Crighton Chief Executive Officer and Announces New Role for Founding CEO, Martin Murphy
12/10/2019 / 15:00 - GlobeNewswire - Avadel Pharmaceuticals Appoints Dr. Mark McCamish to its Board of Directors
12/10/2019 / 14:00 - GlobeNewswire - Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQ® Assay
12/09/2019 / 14:00 - GlobeNewswire - Nkarta Therapeutics Expands Senior Management Team with Key Hires in Finance and Clinical Development
12/09/2019 / 14:00 - GlobeNewswire - CytomX Therapeutics Announces New Employment Inducement Grants
12/06/2019 / 22:06 - GlobeNewswire
Real-time